CSIMarket
 


Conformis inc   (CFMS)
Other Ticker:  
 

Cumulative Conformis Inc 's Working Capital Ratio for Trailing Twelve Months Period

CFMS's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CFMS Working Capital Ratio for Trailing Twelve Months Period

(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Current Liabilities Growth -43.88 % -31.14 % -24.74 % 16.22 % 16.56 %
Y / Y Current Assets Growth -45.8 % -39.11 % -37.53 % -35.62 % -32.19 %
Working Capital Ratio for Trailing Twelve Months Period 6.25 6.3 6.57 6.91 7.99
Total Ranking # 693 # 750 # 834 # 795 # 824
Seq. Current Liabilities Growth -10.66 % -18.54 % -22.15 % -0.94 % 9.61 %
Seq. Current Assets Growth -19.23 % -14.7 % -10.74 % -11.87 % -9.25 %


Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2023
On the trailing twelve months basis Despite year on year decrease in Conformis Inc 's average Current Liabilities to $9 millions, Working Capital Ratio for Trailing Twelve Months Period to 6.25 below company average Working Capital Ratio for Trailing Twelve Months Period.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Equipment & Supplies industry 54 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Conformis Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about CFMS
Working Capital Ratio CFMS in the most recent quarter
Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 55
Sector # 373
S&P 500 # 578


Working Capital Ratio for Trailing Twelve Months Period Statistics
High Average Low
8.1 4.74 1.89
(Mar 31 2022)   (Dec 31 2020)




Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2023, within Medical Equipment & Supplies Industry Working Capital Ratio for Trailing Twelve Months Period
Utah Medical Products Inc  16.29 
Cvrx inc  16.20 
Neurometrix Inc   15.45 
Modular Medical Inc   14.52 
Vicarious Surgical Inc   14.10 
Sight Sciences Inc   13.75 
Novocure Limited  13.56 
Hyperfine Inc   13.50 
Collplant Biotechnologies Ltd   12.29 
Femasys Inc   12.28 
Transmedics Group Inc   12.20 
Inmode Ltd   12.14 
Vivos Inc  11.91 
The Beauty Health Company  11.75 
Neuropace Inc   11.06 
Rxsight Inc   10.81 
Iradimed Corporation  10.27 
Orchestra Biomed Holdings Inc   10.06 
Lyra Therapeutics Inc   9.94 
Si bone inc   9.73 
Abiomed Inc   9.43 
Procept Biorobotics Corporation  9.29 
Helius Medical Technologies inc   9.24 
Pulmonx Corporation  9.17 
Aethlon Medical Inc   9.16 
Vivani Medical Inc   8.98 
Akili Inc   8.94 
Axonics Inc   8.93 
Inari Medical Inc   8.91 
Heartbeam Inc   8.60 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com